Back to Search Start Over

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study

Authors :
Boyd, Mark M.A.
Fontas, Eric
Phillips, Andrew N.
Bonnet, Fabrice
Reiss, Peter
Lundgren, Jens D D J.
Law, Matthew
Mocroft, Amanda
Ryom, Lene
d'Arminio Monforte, Antonella
Sabin, Caroline
El-Sadr, W.M.
Hatleberg, Camilla Ingrid
De Wit, Stéphane
Weber, Rainer
Boyd, Mark M.A.
Fontas, Eric
Phillips, Andrew N.
Bonnet, Fabrice
Reiss, Peter
Lundgren, Jens D D J.
Law, Matthew
Mocroft, Amanda
Ryom, Lene
d'Arminio Monforte, Antonella
Sabin, Caroline
El-Sadr, W.M.
Hatleberg, Camilla Ingrid
De Wit, Stéphane
Weber, Rainer
Source :
PLoS medicine, 14 (11
Publication Year :
2017

Abstract

BACKGROUND: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study has developed predictive risk scores for cardiovascular disease (CVD) and chronic kidney disease (CKD, defined as confirmed estimated glomerular filtration rate [eGFR] ≤ 60 ml/min/1.73 m2) events in HIV-positive people. We hypothesized that participants in D:A:D at high (>5%) predicted risk for both CVD and CKD would be at even greater risk for CVD and CKD events.<br />SCOPUS: ar.j<br />info:eu-repo/semantics/published

Details

Database :
OAIster
Journal :
PLoS medicine, 14 (11
Notes :
1 full-text file(s): application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1014239972
Document Type :
Electronic Resource